Status:
COMPLETED
mHealth Intervention for Older Adults
Lead Sponsor:
Boston College
Collaborating Sponsors:
Joslin Diabetes Center
Conditions:
Type2 Diabetes
Obesity
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This is a pilot study to test the feasibility and acceptability of a self-regulation theory-based mHealth behavior intervention for overweight or obese older adults with T2DM.
Detailed Description
This is a pilot study to test the feasibility and acceptability of a self-regulation theory-based mHealth behavior intervention for overweight or obese older adults with T2DM. The main purpose of the ...
Eligibility Criteria
Inclusion
- \>=65 years of age;
- BMI between 27-40kg/m2
- Availability of wireless Internet service at home;
- Stable body weight during the previous year (i.e., ±10 pounds) ;
- Not being enrolled in another weight loss program in the past six months;
- Diagnosed with type 2 diabetes for at least 2 years;
- Prescribed insulin or oral medications for at least 1 year;
- No changes in medications for at least 6 months before enrolling in the study;
- Use the LoseIt! app on their computer or smartphone for the 5-day practice period;
- Able to read, write and speak English.
Exclusion
- Planning frequent travel, vacations or relocation in next 3 months;
- Current use of weight loss medication;
- Have a history of bariatric surgery;
- Have participated in diabetes education in the previous 12 months;
- Are unable to walk 2 blocks, or had an amputation of a lower limb, severe arthritis or other medical condition that prevents walking for exercise;
- Have severe complications of diabetes, including renal disease (albumin/creatinine \>300 μg /mg), severe peripheral diabetic neuropathy, severe peripheral vascular disease, symptomatic autonomic neuropathy, history of myocardial infarction, congestive heart failure, or other severe cardiac disease or severe hypertension (systolic blood pressure greater than 160/90 mmHg);
- Have a diagnosis of a serious mental illness, e.g. schizophrenia, bipolar disorder, substance abuse, and/or eating disorders;
- Have severe visual, hearing or cognitive impairments (e.g., dementia, intellectual disability);
- Unable or unwilling to use the mHealth technology equipment (toolkit) for data collection;
- Do not speak, read and write English.
Key Trial Info
Start Date :
April 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2018
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03398590
Start Date
April 12 2017
End Date
May 30 2018
Last Update
October 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Joslin Diabetes Center
Boston, Massachusetts, United States, 02215